I have been reading a bit into the three cortisol studies that have been done in the 90’s.
I would like to discuss the ideas that come out of a critical evaluation of these studies.
A lot of it is stating the obvious in my mind, but I still think it’s worth discussing. How could we repeat these studies and how would we do them differentely with the knowledge we have now? What lessons can we learn from these studies?
Why I personally read into these studies, is because I have found a lot of benefit from taking low dose cortisol. I take a physiological dose of 25mg spread over 4 or 5 time a day to avoid peaks. This seems to be the newest way that low cortisol in panhypopituatory disease is managed. Taking this treatment has helped a few very annoying symptoms (nausea, weakness) and gave me a much more steady energy during the day. So this is in no way a cure, but it did help me start work again for 10 hours a week.
Use of cortisol is specifically discouraged in the dutch guidelines. A lot of doctors I meet have been very negative towards my use of cortisol, they all cite different dosages as low dose cortisol and frequentely state the negative effects it can have and the suppresion on the adrenal glands it can cause. (We know from panhypopituatory studies that physicological doses do not have the risks that higher doses (given in inflammatory disease) do have).
Do I think low cortisol treatment could treat Me/cfs? No, I do not. If low cortisol was me/cfs we would have known by now. My personal hypothesis though is that me/cfs is probably 2 or more diseases, it’s also mutisystemic in nature, so I hypothesise that (as long as we don’t find a cure where the primary problem is adressed) different treatments are necessary to alleviate symptoms in one person and we will be needing a combination of different treatments in different people as well.
First thing that is interesting, is that at least two of the three studies have been done by fierce proponents of CBT type treatment.
In reading the studies, I imediately spotted a few problems that we have found in the CBT/GET studies as well:
Average illness duration is 4 years in one study, it’s not clear how many people were ill for a long time or how many people were ill for just 6 months. It is not clear how that differed in the active arm and the placebo arm?
The dosage that was used was different in every study. One study used 5 mg (no effects were noted), one study used 5-10mg (study had a postive outcome), the third used 25-35mg (study had a positive outcome). In the last study they found some evidence of suppresion of the adrenal glands, which comes as no suprise as the dose is really high and they gave a morning dose of 20-30mg, which is (with the knowlegde we have today) extremely high.
Thoughts I had:
I get why some people would not find these kind of studies very interesting, it will not give us a cure and it seems a bit simplistic. I feel that these cheap and easy ways of treating symptoms could give us some options, while at the same time getting the disease out of the cbt/get hands and into the hands of internal medicine specialists. Positive results could therefore also spark interest in specialist, researchers and pharmaceutical companies.
I feel that a lot of studies into me/cfs are very fundamental, theoretical and not likely to produce some kind of benefit for patients in the short term.
I would very much like to see this kind of simple research repeated in ways that will actually give us interesting results. Research that will give us some short term benefits and treatments.
What do you think about this kind of research? Interesting? Not interesting? Do you see any flaws in this kind of thinking, any suggestions?
What kind of other simple treatments are discouraged in this way in guidelines? Do you see any other kind of simple treatment where it could be benificial to repeat research on with knowledge we have today?
I am writing this down, partly because reading about these kinds of studies frustrates me enormously. Partly because I am thinking of ways in which I could be participating in me/cfs research.
I would like to discuss the ideas that come out of a critical evaluation of these studies.
A lot of it is stating the obvious in my mind, but I still think it’s worth discussing. How could we repeat these studies and how would we do them differentely with the knowledge we have now? What lessons can we learn from these studies?
Why I personally read into these studies, is because I have found a lot of benefit from taking low dose cortisol. I take a physiological dose of 25mg spread over 4 or 5 time a day to avoid peaks. This seems to be the newest way that low cortisol in panhypopituatory disease is managed. Taking this treatment has helped a few very annoying symptoms (nausea, weakness) and gave me a much more steady energy during the day. So this is in no way a cure, but it did help me start work again for 10 hours a week.
Use of cortisol is specifically discouraged in the dutch guidelines. A lot of doctors I meet have been very negative towards my use of cortisol, they all cite different dosages as low dose cortisol and frequentely state the negative effects it can have and the suppresion on the adrenal glands it can cause. (We know from panhypopituatory studies that physicological doses do not have the risks that higher doses (given in inflammatory disease) do have).
Do I think low cortisol treatment could treat Me/cfs? No, I do not. If low cortisol was me/cfs we would have known by now. My personal hypothesis though is that me/cfs is probably 2 or more diseases, it’s also mutisystemic in nature, so I hypothesise that (as long as we don’t find a cure where the primary problem is adressed) different treatments are necessary to alleviate symptoms in one person and we will be needing a combination of different treatments in different people as well.
First thing that is interesting, is that at least two of the three studies have been done by fierce proponents of CBT type treatment.
In reading the studies, I imediately spotted a few problems that we have found in the CBT/GET studies as well:
- Use of fukuda criteria, not very strict criteria, no way of knowing who had PEM as a symptom.
- Subjective outcomes only, all different kind of depression, mood and anxiety scales are measured (nothing I would find relevant in the disease I experience)
- Where are patients recruited? At GP’s? In third line psychiatric clinics? (Two studies are done by welknown psychiatrist..) I couldn’t find the details, but I think these biases are particularly important in this disease.
Average illness duration is 4 years in one study, it’s not clear how many people were ill for a long time or how many people were ill for just 6 months. It is not clear how that differed in the active arm and the placebo arm?
The dosage that was used was different in every study. One study used 5 mg (no effects were noted), one study used 5-10mg (study had a postive outcome), the third used 25-35mg (study had a positive outcome). In the last study they found some evidence of suppresion of the adrenal glands, which comes as no suprise as the dose is really high and they gave a morning dose of 20-30mg, which is (with the knowlegde we have today) extremely high.
Thoughts I had:
- This very simple and cheap treatment is discouraged in the guidelines. Why are these recommendations in the guidelines? The conclusion to discourage this possibillity of treatment is not supported by these studies at all.
- It’s interesting to see that these medical studies suffer fom exactly the same problems as the cbt/get studies.
- Yes, we would need more studies to support the (broad) use of this treatment. I’m thinking of ways how you would do such a study now: Objective outcomes (stepcount, hours spend upright, hours worked. as well as daily measuring of important physical symptoms (headache, nausea etc)
- I would think that actually measuring if these patients had low cortisol, when you want to correct it with medication is important. One of the selection criteria should include, people having some kind of test of low cortisol (there is a lot of discussion about the right way to test low cortisol). They did measure this in one of the studies, but there was no comparison made between people responding to the treatment, who had low cortisol in the first place vs. people who did not have low cortisol.
I get why some people would not find these kind of studies very interesting, it will not give us a cure and it seems a bit simplistic. I feel that these cheap and easy ways of treating symptoms could give us some options, while at the same time getting the disease out of the cbt/get hands and into the hands of internal medicine specialists. Positive results could therefore also spark interest in specialist, researchers and pharmaceutical companies.
I feel that a lot of studies into me/cfs are very fundamental, theoretical and not likely to produce some kind of benefit for patients in the short term.
I would very much like to see this kind of simple research repeated in ways that will actually give us interesting results. Research that will give us some short term benefits and treatments.
What do you think about this kind of research? Interesting? Not interesting? Do you see any flaws in this kind of thinking, any suggestions?
What kind of other simple treatments are discouraged in this way in guidelines? Do you see any other kind of simple treatment where it could be benificial to repeat research on with knowledge we have today?
I am writing this down, partly because reading about these kinds of studies frustrates me enormously. Partly because I am thinking of ways in which I could be participating in me/cfs research.